Literature DB >> 15584796

Development and preliminary validation of the physiological hyperarousal scale for children.

Jeff Laurent1, Salvatore J Catanzaro, Thomas E Joiner.   

Abstract

Considerable empirical support exists for the positive affect and negative affect components of the tripartite model of anxiety and depression proposed by L. A. Clark and D. Watson (1991); however, less attention has been paid to the physiological hyperarousal component of the model. The development of the Physiological Hyperarousal Scale for Children (PH-C; J. Laurent, S. J. Catanzaro, & T. E. Joiner Jr., 1995) is described. The psychometric properties of items are examined using students in Grades 6-12 (N = 398). Initial scale validation includes a joint factor analysis with the Positive and Negative Affect Scale for Children (PANAS-C; J. Laurent et al., 1999; J. Laurent, K. Potter, & S. J. Catanzaro, 1994). The relationship between the PH-C and existing measures that tap related constructs is examined. Together, the PH-C and PANAS-C provide a means to assess tripartite model constructs useful in differentiating anxiety and depression. Copyright 2004 APA.

Entities:  

Mesh:

Year:  2004        PMID: 15584796     DOI: 10.1037/1040-3590.16.4.373

Source DB:  PubMed          Journal:  Psychol Assess        ISSN: 1040-3590


  13 in total

1.  Confirmatory factor structure of anxiety and depression: evidence of item variance across childhood.

Authors:  Khrista R Boylan; Jessie L Miller; Tracy Vaillancourt; Peter Szatmari
Journal:  Int J Methods Psychiatr Res       Date:  2011-10-18       Impact factor: 4.035

2.  Variations in the influence of parental socialization of anxiety among clinic referred children.

Authors:  Lindsay E Holly; Armando A Pina
Journal:  Child Psychiatry Hum Dev       Date:  2015-06

3.  Streamlined Prevention and Early Intervention for Pediatric Anxiety Disorders: A Randomized Controlled Trial.

Authors:  Armando A Pina; Nancy A Gonzales; Gina L Mazza; Heather J Gunn; Lindsay E Holly; Ryan D Stoll; Julia Parker; Amanda Chiapa; Henry Wynne; Jenn-Yun Tein
Journal:  Prev Sci       Date:  2020-05

4.  Relevance of the tripartite dimensions of affect for anxiety and depression in youth: examining sex and psychopathology status.

Authors:  Marleen De Bolle; Mieke Decuyper; Barbara De Clercq; Filip De Fruyt
Journal:  J Abnorm Child Psychol       Date:  2010-10

5.  Remote monitoring of pain and symptoms using wireless technology in children and adolescents with sickle cell disease.

Authors:  Eufemia Jacob; Joana Duran; Jennifer Stinson; Mary Ann Lewis; Lonnie Zeltzer
Journal:  J Am Assoc Nurse Pract       Date:  2012-07-12       Impact factor: 1.165

6.  Psychometric Evaluation of the PROMIS® Pediatric Psychological and Physical Stress Experiences Measures.

Authors:  Katherine B Bevans; William Gardner; Kathleen A Pajer; Brandon Becker; Adam Carle; Carole A Tucker; Christopher B Forrest
Journal:  J Pediatr Psychol       Date:  2018-07-01

7.  Construct Validity of Pediatric PROMIS Computerized Adaptive Testing Measures in Children With Adolescent Idiopathic Scoliosis.

Authors:  Stuart L Mitchell; Kevin H McLaughlin; Keith R Bachmann; Paul D Sponseller; Lisa M Reider
Journal:  J Pediatr Orthop       Date:  2022-06-15       Impact factor: 2.537

Review 8.  Comorbidity of anxiety and depression in children and adolescents: 20 years after.

Authors:  Colleen M Cummings; Nicole E Caporino; Philip C Kendall
Journal:  Psychol Bull       Date:  2013-11-11       Impact factor: 17.737

9.  Relations among perceived control over anxiety-related events, worry, and generalized anxiety disorder in a sample of adolescents.

Authors:  Jamie L Frala; Ellen W Leen-Feldner; Heidemarie Blumenthal; Carolina C Barreto
Journal:  J Abnorm Child Psychol       Date:  2010-02

10.  Study protocol: imaging brain development in the Childhood to Adolescence Transition Study (iCATS).

Authors:  Julian G Simmons; Sarah L Whittle; George C Patton; Paul Dudgeon; Craig Olsson; Michelle L Byrne; Lisa K Mundy; Marc L Seal; Nicholas B Allen
Journal:  BMC Pediatr       Date:  2014-04-30       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.